Literature DB >> 3023901

Nucleotide sequence of the two rat cellular rasH genes.

M Ruta, R Wolford, R Dhar, D Defeo-Jones, R W Ellis, E M Scolnick.   

Abstract

We present the nucleotide sequence of the coding region of the rat c-rasH-1 gene and a partial sequence analysis of the rat c-rasH-2 gene. By comparing these sequences with the Harvey murine sarcoma virus ras gene, we predict that the p21 protein encoded by the Harvey virus differs from the cellular c-rasH-1-encoded p21 at only two amino acids; those at positions 12 and 59. Alterations at each of these positions may play a role in activating the viral p21 protein. The c-rasH-2 gene is likely to be a nonfunctional pseudogene because it lacks introns, cannot be activated to transform NIH 3T3 cells, and differs in sequence from both c-rasH-1 and v-rasH at several base pair positions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023901      PMCID: PMC367698          DOI: 10.1128/mcb.6.5.1706-1710.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  29 in total

1.  The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes.

Authors:  R W Ellis; D Defeo; T Y Shih; M A Gonda; H A Young; N Tsuchida; D R Lowy; E M Scolnick
Journal:  Nature       Date:  1981-08-06       Impact factor: 49.962

2.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

3.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

4.  Identification of a sarcoma virus-coded phosphoprotein in nonproducer cells transformed by Kirsten or Harvey murine sarcoma virus.

Authors:  T Y Shih; M O Weeks; H A Young; E M Scholnick
Journal:  Virology       Date:  1979-07-15       Impact factor: 3.616

5.  Molecular cloning of the Harvey sarcoma virus closed circular DNA intermediates: initial structural and biological characterization.

Authors:  G L Hager; E H Chang; H W Chan; C F Garon; M A Israel; M A Martin; E M Scolnick; D R Lowy
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

6.  Mapping of transforming region of the Harvey murine sarcoma virus genome by using insertion-deletion mutants constructed in vitro.

Authors:  C M Wei; D R Lowy; E M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

7.  Guanine nucleotide-binding and autophosphorylating activities associated with the p21src protein of Harvey murine sarcoma virus.

Authors:  T Y Shih; A G Papageorge; P E Stokes; M O Weeks; E M Scolnick
Journal:  Nature       Date:  1980-10-23       Impact factor: 49.962

8.  Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene.

Authors:  L F Parada; C J Tabin; C Shih; R A Weinberg
Journal:  Nature       Date:  1982-06-10       Impact factor: 49.962

9.  Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus.

Authors:  E H Chang; M E Furth; E M Scolnick; D R Lowy
Journal:  Nature       Date:  1982-06-10       Impact factor: 49.962

10.  Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus.

Authors:  D DeFeo; M A Gonda; H A Young; E H Chang; D R Lowy; E M Scolnick; R W Ellis
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

View more
  21 in total

1.  Hydrostatic pressure and the actomyosin cortex drive mitotic cell rounding.

Authors:  Martin P Stewart; Jonne Helenius; Yusuke Toyoda; Subramanian P Ramanathan; Daniel J Muller; Anthony A Hyman
Journal:  Nature       Date:  2011-01-02       Impact factor: 49.962

2.  A splicing enhancer in the 3'-terminal c-H-ras exon influences mRNA abundance and transforming activity.

Authors:  D Y Hwang; J B Cohen
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

3.  A new member of the ras gene superfamily identified in a rat liver cell line.

Authors:  C Bucci; R Frunzio; L Chiariotti; A L Brown; M M Rechler; C B Bruni
Journal:  Nucleic Acids Res       Date:  1988-11-11       Impact factor: 16.971

4.  Fast repair of O6-ethylguanine, but not O6-methylguanine, in transcribed genes prevents mutation of H-ras in rat mammary tumorigenesis induced by ethylnitrosourea in place of methylnitrosourea.

Authors:  J Engelbergs; J Thomale; A Galhoff; M F Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

5.  The 5' splice site: phylogenetic evolution and variable geometry of association with U1RNA.

Authors:  M Jacob; H Gallinaro
Journal:  Nucleic Acids Res       Date:  1989-03-25       Impact factor: 16.971

6.  Transforming function of proto-ras genes depends on heterologous promoters and is enhanced by specific point mutations.

Authors:  A K Chakraborty; K Cichutek; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

7.  Development of transforming function during transduction of proto-ras into Harvey sarcoma virus.

Authors:  M Lang; I Treinies; P H Duesberg; R Kurth; K Cichutek
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

Review 8.  Ras/MAPK signaling from endomembranes.

Authors:  Nicole Fehrenbacher; Dafna Bar-Sagi; Mark Philips
Journal:  Mol Oncol       Date:  2009-06-26       Impact factor: 6.603

9.  Ras gene mutation-independent tumours in the intestine of the rat by a single dose of N-methyl-N-nitrosourea.

Authors:  V Waldmann; H M Rabes
Journal:  Int J Exp Pathol       Date:  1992-08       Impact factor: 1.925

10.  Expression of the hepatitis delta virus large and small antigens in transgenic mice.

Authors:  S Guilhot; S N Huang; Y P Xia; N La Monica; M M Lai; F V Chisari
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.